Silvan Tuerkcan
Stock Analyst at JMP Securities
(0)
# 3774
Out of 5,269 analysts
174
Total ratings
35.21%
Success rate
-0.45%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics | Reiterates: Market Outperform | 86 86 | 43.88 | 95.99% | 14 | Feb 13, 2025 | |
Exelixis | Maintains: Market Outperform | 41 41 | 38.77 | 5.75% | 20 | Jan 27, 2025 | |
Jasper Therapeutics | Reiterates: Market Outperform | 70 70 | 6.17 | 1034.52% | 5 | Jan 10, 2025 | |
Context Therapeutics | Initiates Coverage On: Market Outperform | 4 | 0.88 | 354.55% | 1 | Jan 8, 2025 | |
enGene Holdings | Reiterates: Market Outperform | 18 18 | 6.08 | 196.05% | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 7 7 | 0.52 | 1246.15% | 5 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 21 21 | 3.17 | 562.46% | 10 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 12 12 | 1.01 | 1088.12% | 11 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 15 | 5.38 | 178.81% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 10 | 2.41 | 314.94% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 20 20 | 3.49 | 473.07% | 11 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 5 5 | 1.61 | 210.56% | 11 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 12 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 16 18 | 12.67 | 42.07% | 9 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 17 17 | 5.48 | 210.22% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 6 6 | 1.36 | 341.18% | 6 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 240 280 | 289 | -3.11% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 9 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 18 18 | 14.25 | 26.32% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 10 | Jan 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 2 3 | 7.85 | -61.78% | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Oct 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 200 210 | n/a | n/a | 8 | Jun 30, 2020 |